Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT07266675
Recruiting Observational

Post-Acute Phase of Cardiogenic Shock

NCT07266675 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Mackay Memorial Hospital
Phase
Observational
Started
2024-07-19
Last updated
2025-12-05

Condition(s) studied

Cardiogenic Shock

Study summary

Epidemiology studies showed that the burden of cardiogenic shock (CS) persistently high, with increasing annual medical expenses and steady prevalence. In-hospital and one-year mortality reduce annually. Hence, there are increasing number of patients who survive to hospital discharge but they will face further challenges in the subacute stage after hospital discharge. However, there are still insufficient studies focusing on this issue. Establishment of a healthcare neatwork to help hospital survivors of CS return society safely is critical.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Hospital survivors of cardiogenic shock Exclusion Criteria: * Age \< 18 years。 * Patient or family refuse follow-up. * Patient died within hospital stay.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
MacKay Memorial Hospital Taipei Taiwan Recruiting

More Mackay Memorial Hospital trials in Taiwan

CKD-Heart: Heart Failure Prediction in Asian CKD Patients Active, not recruiting
Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease Recruiting
The Impact of Multimedia Childbirth Prediction on Parturients and Their Spouses Recruiting
Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders Recruiting
The Intervention of Lactobacillus Plantarum Probiotics in Adult Autistic Spectrum Disorders Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07266675 on ClinicalTrials.gov ↗ ← All trials in Taiwan